… immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
during COVID-19 is essential when aiming to purposely combine antivirals with the use of …

… to evaluate the effectiveness of COVID-19 control measures and increase our understanding
of the immunology behind COVID-19. Combining molecular diagnostics with serological …

… of coronavirus disease 2019 (COVID-19), we read with great interest the Comment in The
Lancet Infectious Diseases by Justin Stebbing and colleagues 1 about the potential use of …

… be useful for patients of COVID-19 and, in combination with Arbidol, … Use of ribavirin in
combination with LPV/r in patients with … countries to treat COVID-19, it is clear that the use of these …

… uses a single parameter to identify severe from moderate patients. Panel B is a ROC plot
that uses the combined … D are scatter plots that use the combined parameters for comparison …

… use in one COVID-19 patient [7]. During the time when this commentary was reviewed, an
observational study of the compassionate use of remdesivir in 61 COVID-19 … 13% in COVID-19 …

… burden, such that early use of an anti-spike monoclonal antibody combination could reduce
this risk. In support of this hypothesis, we found that patients in the placebo group who had a …

… The use of LPV appears effective in this study, but digestive adverse effects and hypokalemia
should be a concern by clinicians after beginning this drug. More clinical evidence is also …

… This combination therapy retains neutralization potency … In outpatients with Covid-19, the
use of REGEN-COV has been … could be used to prevent Covid-19 among persons with ongoing …

… To obtain the best experience, we recommend you use a more up to date browser (or turn
… (IgM and IgG) combined with nucleic acid assays provides the basis of COVID-19 diagnosis. …